<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Tang Z</submitter><funding>Natural Science Foundation of Hunan Province</funding><funding>National Natural Science Foundation of China</funding><pagination>747360</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8606537</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>12</volume><pubmed_abstract>&lt;b>Background:&lt;/b> Late-onset multiple acyl-CoA dehydrogenase deficiency (LO-MADD) describes a curable autosomal recessive genetic disease caused by &lt;i>ETFDH&lt;/i> mutations that result in defects in ETF-ubiquinone oxidoreductase. Almost all patients are responsive to riboflavin. This study describes the clinical presentations and genetic characteristics of five LO-MADD patients. &lt;b>Methods:&lt;/b> From 2018 to 2021, we collected clinical and genetic data on five patients diagnosed with LO-MADD at our hospital and retrospectively analyzed their clinical characteristics, laboratory examination, electromyography, muscle biopsy, genetic analysis, and outcome data. &lt;b>Results:&lt;/b> This study included three males and two females with mean onset age of 37.8 years. Fluctuating exercise intolerance was</pubmed_abstract><journal>Frontiers in neurology</journal><pubmed_title>Clinical Presentations and Genetic Characteristics of Late-Onset MADD Due to &lt;i>ETFDH&lt;/i> Mutations in Five Patients: A Case Series.</pubmed_title><pmcid>PMC8606537</pmcid><funding_grant_id>81901306</funding_grant_id><funding_grant_id>2021JJ40857</funding_grant_id><pubmed_authors>Tang Z</pubmed_authors><pubmed_authors>Tang J</pubmed_authors><pubmed_authors>Chen Q</pubmed_authors><pubmed_authors>Fang J</pubmed_authors><pubmed_authors>Huang H</pubmed_authors><pubmed_authors>He M</pubmed_authors><pubmed_authors>Luo Y</pubmed_authors><pubmed_authors>Gao S</pubmed_authors><pubmed_authors>Yan W</pubmed_authors><pubmed_authors>Shi X</pubmed_authors></additional><is_claimable>false</is_claimable><name>Clinical Presentations and Genetic Characteristics of Late-Onset MADD Due to &lt;i>ETFDH&lt;/i> Mutations in Five Patients: A Case Series.</name><description>&lt;b>Background:&lt;/b> Late-onset multiple acyl-CoA dehydrogenase deficiency (LO-MADD) describes a curable autosomal recessive genetic disease caused by &lt;i>ETFDH&lt;/i> mutations that result in defects in ETF-ubiquinone oxidoreductase. Almost all patients are responsive to riboflavin. This study describes the clinical presentations and genetic characteristics of five LO-MADD patients. &lt;b>Methods:&lt;/b> From 2018 to 2021, we collected clinical and genetic data on five patients diagnosed with LO-MADD at our hospital and retrospectively analyzed their clinical characteristics, laboratory examination, electromyography, muscle biopsy, genetic analysis, and outcome data. &lt;b>Results:&lt;/b> This study included three males and two females with mean onset age of 37.8 years. Fluctuating exercise intolerance was</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021</publication><modification>2025-04-19T08:26:25.364Z</modification><creation>2022-02-11T13:12:49.081Z</creation></dates><accession>S-EPMC8606537</accession><cross_references><pubmed>34819910</pubmed><doi>10.3389/fneur.2021.747360</doi></cross_references></HashMap>